Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
351
CALL
DELISTED
Splunk Inc
SPLK
| $163M | 0.04% |
1,840,300
+18,500
| +1% | +$2.03M |
|
352
PayPal
PYPL
$49.9B
| $162M | 0.04% |
2,323,310
+1,894,735
| +442% | +$164M |
|
353
CALL
Royal Caribbean
RCL
$81.4B
| $162M | 0.04% |
4,637,600
+2,022,000
| +77% | +$126M |
|
|
DOCU
354
PUT
DocuSign
DOCU
$11B
| $162M | 0.04% |
2,819,100
-1,311,900
| -32% | -$106M |
|
355
HubSpot
HUBS
$10.6B
| $161M | 0.04% |
535,059
+275,734
| +106% | +$101M |
|
356
PUT
CVS Health
CVS
$120B
| $161M | 0.04% |
1,736,000
-266,400
| -13% | -$26M |
|
357
CALL
Enphase Energy
ENPH
$5.57B
| $161M | 0.04% |
823,800
-72,600
| -8% | -$13.1M |
|
358
CALL
Regeneron Pharmaceuticals
REGN
$81.7B
| $160M | 0.04% |
271,200
+87,700
| +48% | +$57M |
|
359
CALL
GE Aerospace
GE
$380B
| $160M | 0.04% |
4,027,641
+578,020
| +17% | +$28M |
|
360
Roblox
RBLX
$25.6B
| $160M | 0.04% |
4,859,338
+3,814,758
| +365% | +$128M |
|
|
361
CALL
Roblox
RBLX
$25.6B
| $160M | 0.04% |
4,856,000
+2,028,200
| +72% | +$68.1M |
|
362
ConocoPhillips
COP
$151B
| $159M | 0.04% |
1,767,187
+457,005
| +35% | +$47.1M |
|
363
Workday
WDAY
$43B
| $158M | 0.04% |
1,133,685
+354,491
| +45% | +$64.4M |
|
364
CALL
American Express
AXP
$229B
| $158M | 0.04% |
1,139,300
-102,600
| -8% | -$16.9M |
|
365
Monster Beverage
MNST
$89B
| $157M | 0.04% |
6,793,404
-3,683,604
| -35% | -$80.1M |
|
|
PPL
366
PPL Corp
PPL
$26.6B
| $157M | 0.04% |
5,784,238
+5,507,499
| +1,990% | +$158M |
|
367
CALL
RH
RH
$3.36B
| $157M | 0.04% |
737,900
+11,200
| +2% | +$3.32M |
|
368
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.7B
| $156M | 0.04% |
1,217,300
-270,300
| -18% | -$35.4M |
|
|
PXD
369
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $156M | 0.04% |
698,300
+145,064
| +26% | +$36.8M |
|
370
PUT
Oracle
ORCL
$433B
| $155M | 0.04% |
2,215,600
+88,700
| +4% | +$6.49M |
|
|
371
PUT
Workday
WDAY
$43B
| $154M | 0.04% |
1,105,600
+206,900
| +23% | +$37.6M |
|
372
PUT
Valero Energy
VLO
$93.9B
| $154M | 0.04% |
1,449,300
+497,500
| +52% | +$58.9M |
|
373
CALL
Etsy
ETSY
$7.3B
| $154M | 0.04% |
2,100,800
+499,400
| +31% | +$45.6M |
|
374
Conagra Brands
CAG
$7.05B
| $153M | 0.04% |
4,474,450
+3,623,933
| +426% | +$123M |
|
375
Gartner
IT
$11.6B
| $153M | 0.04% |
630,831
+222,391
| +54% | +$59.2M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.